Get an Accurate Diagnosis & Specialised Treatment For Your Condition Today
Consult our dual fellowship-trained surgeon for a personalised treatment plan today.
MBBS
MMed
MRCS (IRE)
FRCSED
FAMS
Hepatitis B and Hepatitis C are liver infections caused by different viruses. Hepatitis B is caused by the Hepatitis B virus (HBV), while Hepatitis C is caused by the Hepatitis C virus (HCV). Both infections can lead to severe liver complications such as cirrhosis, liver cancer, and liver failure.
Hepatitis B and Hepatitis C are serious liver infections caused by different viruses, with distinct modes of transmission, symptoms, and management approaches. Understanding these infections is crucial for effective prevention, early detection, and treatment to prevent severe liver damage and complications.
Hepatitis B (HBV) and Hepatitis C (HCV) viruses have distinct but sometimes overlapping modes of transmission, reflecting their epidemiology and the risk factors associated with infection.
The signs and symptoms of Hepatitis B and C can vary widely among people, with some experiencing acute symptoms shortly after infection, while others may remain asymptomatic for years, particularly in chronic cases. Common symptoms for both Hepatitis B and C may include:
For Hepatitis B, tests identify markers such as the hepatitis B surface antigen (HBsAg) and hepatitis B core antibody (anti-HBc). For Hepatitis C, the hepatitis C antibody test (anti-HCV) is initially used, followed by an RNA test to confirm active infection.
These tests measure levels of liver enzymes and proteins in the blood, providing information on liver health and indicating potential damage from hepatitis.
While less commonly performed today due to advancements in non-invasive testing, a liver biopsy may still be recommended in certain cases to assess the degree of liver damage and inflammation.
Ultrasound, CT scans, or MRIs may be used to visualise the liver and check for signs of liver cirrhosis or liver cancer.
Consult our dual fellowship-trained surgeon for a personalised treatment plan today.
The treatment of Hepatitis B and C varies based on several factors, including the type of infection (acute or chronic), the severity of liver damage, and the presence of any co-existing conditions.
Preventing Hepatitis B and C is key to reducing the burden of these liver diseases. Effective strategies include:
A safe and effective vaccine is available for Hepatitis B and is recommended for all infants at birth, unvaccinated adults at risk of infection, and healthcare workers. No vaccine is currently available for Hepatitis C.
Using sterile needles for tattoos, piercings, and medical procedures. For individuals who inject drugs, accessing clean needle exchange programs can significantly reduce the risk of Hepatitis C.
Ensuring all blood products are screened for Hepatitis B and C before transfusion.
Using barrier protection during sexual activity, especially with new or multiple partners, to reduce the risk of Hepatitis B.
Chronic infection with Hepatitis B or C can lead to serious complications over time, impacting liver function and overall health.
Scar tissue replaces healthy liver tissue, impeding liver function. This condition can lead to liver failure.
Both Hepatitis B and C are leading causes of liver cancer, specifically hepatocellular carcinoma.
Advanced liver disease can progress to liver failure, a life-threatening condition where the liver can no longer perform its critical functions.
Hepatitis C, in particular, can be associated with conditions affecting the kidneys.
Hepatitis C can also lead to problems with blood vessels, such as vasculitis.
MBBS (SG)
MMed (Surg)
MRCS (Ire)
FRCSEd (Gen)
FAMS (Surg)
Dr Thng Yongxian is a dual fellowship-trained Hepatopancreatobiliary & General Surgeon who has performed over 6000 surgical procedures.
He pursued his subspecialty training in Hepatopancreatobiliary surgery first in the Department of Hepatopancreatobiliary Surgery, Singapore General Hospital. Following this, he completed a clinical fellowship in Minimally Invasive Hepatopancreatobiliary Surgery at Seoul National University Hospital in Bundang, South Korea.
Dr Thng set up and pioneered the Minimally invasive surgery program for his hospital in complex liver and pancreas cases. His surgeries were featured on live national television. His surgical videos have also been presented at international surgical conferences. He also pioneered the use of capsule colonoscopy for colorectal screening.
Dr Thng has served on various committees at hospital, cluster and ministry level. Dr Thng served as a member of the Ministry of Health (MOH) Laparoscopic cholecystectomy Clinician workgroup for value-driven care (VDC).
Navigating the financial aspects of healthcare can be overwhelming. Allow us to assist you with your insurance claims, enabling you to concentrate on recovery & getting well. Our friendly clinic staff is here to answer any questions you have about insurance or payment options.
Please leave us a message and we will be in touch with you shortly.
820 Thomson Road, #06-05 ,Singapore 574623
Monday-Friday: 9.00am-5.00pm
(Lunch: 1.00-2.00pm)
Saturday: 9.00am-1.00pm
Sunday & PH: Closed
3 Mount Elizabeth, #08-06, Singapore 228510
Monday-Friday: 9.00am-5.00pm
(Lunch: 1.00-2.00pm)
Saturday: 9.00am-1.00pm
Sunday & PH: Closed
38 Irrawaddy Road, #08-43, Singapore 329563
Monday-Friday: 9.00am-5.00pm
(Lunch: 1.00-2.00pm)
Saturday: 9.00am-1.00pm
Sunday & PH: Closed
319 Joo Chiat Place, #05-01, Singapore 427989
Monday-Friday: 9.00am-5.00pm
(Lunch: 1.00-2.00pm)
Saturday, Sunday & PH: Closed
6 Napier Road, #05-10, Singapore 258499
Monday-Friday: 9.00am-5.00pm
(Lunch: 1.00-2.00pm)
Saturday: 9.00am-1.00pm
Sunday & PH: Closed
820 Thomson Road, #06-05 ,Singapore 574623
Monday-Friday: 9.00am-5.00pm
(Lunch: 1.00-2.00pm)
Saturday: 9.00am-1.00pm
Sunday & PH: Closed
Hepatitis B and C cannot be transmitted through casual contact like hugging, sharing eating utensils, or kissing. These viruses are primarily spread through blood-to-blood contact, unsafe sexual practices, and from mother to child during childbirth.
The frequency of liver function tests for people with Hepatitis B or C varies based on their disease stage, treatment regimen, and doctor’s recommendations. Generally, monitoring may occur every 3 to 6 months, but doctors should determine specific intervals.
Yes, co-infection with Hepatitis B and C can occur and presents a more complex treatment challenge. Management typically involves antiviral medications that can target both viruses, but doctors must tailor treatment plans individually.
Hepatitis C can often be cured with a course of direct-acting antiviral medication, leading to a sustained virological response (SVR), meaning no detectable virus remains in the blood 12 weeks after treatment completion. Hepatitis B, however, is not currently curable, but its effects can be managed with ongoing antiviral therapy to control the virus and minimise liver damage. Therefore, people with Hepatitis B may require medication for life to control the virus and prevent complications.